Care Lens
Guideline-aligned care gaps where communicating off-label avapritinib data could help inform clinical decision-making. Each lane links back to the underlying analytics tab and shows its evidence tier.
For medical-affairs and pathway analysis only. This view highlights where communicating off-label data may help close NCCN-aligned care gaps - it does not constitute promotion of off-label use.
Patients in scope
766
ISM · partial response
55
Tier B evidence
ISM · bone / DEXA
711
Tier B evidence
Drill-in · Symptomatic ISM with partial response on avapritinib 25mg
55 patients · relevant data: Avapritinib 50mg (off-label dose) response data
| Patient | Subtype | Region | First-touch | Current LoT bucket | Relevant data |
|---|---|---|---|---|---|
| P100036 | ISM-high | Midwest | PCP | TKI | Avapritinib 50mg (off-label dose) response data |
| P100121 | ISM-high | Northeast | ED | TKI | Avapritinib 50mg (off-label dose) response data |
| P100123 | ISM-high | Midwest | PCP | TKI | Avapritinib 50mg (off-label dose) response data |
| P100127 | ISM-high | South | Gastroenterology | TKI | Avapritinib 50mg (off-label dose) response data |
| P100192 | ISM-high | West | Gastroenterology | TKI | Avapritinib 50mg (off-label dose) response data |
| P100230 | ISM-high | Northeast | Hematology/Oncology | TKI | Avapritinib 50mg (off-label dose) response data |
| P100238 | ISM-low | Northeast | Hematology/Oncology | TKI | Avapritinib 50mg (off-label dose) response data |
| P100274 | ISM-high | West | PCP | TKI | Avapritinib 50mg (off-label dose) response data |
| P100280 | ISM-high | Midwest | PCP | TKI | Avapritinib 50mg (off-label dose) response data |
| P100316 | ISM-low | West | PCP | TKI | Avapritinib 50mg (off-label dose) response data |
| P100368 | ISM-high | Midwest | PCP | TKI | Avapritinib 50mg (off-label dose) response data |
| P100392 | ISM-high | South | PCP | TKI | Avapritinib 50mg (off-label dose) response data |
| P100398 | ISM-high | Midwest | Gastroenterology | TKI | Avapritinib 50mg (off-label dose) response data |
| P100430 | ISM-high | West | PCP | TKI | Avapritinib 50mg (off-label dose) response data |
| P100442 | ISM-high | West | Hematology/Oncology | TKI | Avapritinib 50mg (off-label dose) response data |
| P100443 | ISM-low | Northeast | PCP | TKI | Avapritinib 50mg (off-label dose) response data |
| P100472 | ISM-high | South | Rheumatology | TKI | Avapritinib 50mg (off-label dose) response data |
| P100475 | ISM-high | West | ED | TKI | Avapritinib 50mg (off-label dose) response data |
| P100591 | ISM-low | Midwest | PCP | TKI | Avapritinib 50mg (off-label dose) response data |
| P100606 | ISM-low | South | PCP | TKI | Avapritinib 50mg (off-label dose) response data |
| P100633 | ISM-high | Northeast | Dermatology | TKI | Avapritinib 50mg (off-label dose) response data |
| P100670 | ISM-high | Midwest | PCP | TKI | Avapritinib 50mg (off-label dose) response data |
| P100672 | ISM-low | West | Allergy/Immunology | TKI | Avapritinib 50mg (off-label dose) response data |
| P100771 | ISM-low | West | Allergy/Immunology | TKI | Avapritinib 50mg (off-label dose) response data |
| P100790 | ISM-high | Northeast | Gastroenterology | TKI | Avapritinib 50mg (off-label dose) response data |
Showing first 25 of 55 patients in scope.